- Home
- YJ vs CNSP Comparison
YJ vs CNSP Comparison
Compare YJ & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YJ
- CNSP
- Stock Information
- Founded
- YJ 2015
- CNSP 2017
- Country
- YJ China
- CNSP United States
- Employees
- YJ N/A
- CNSP N/A
- Industry
- YJ Other Specialty Stores
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- YJ Consumer Discretionary
- CNSP Health Care
- Exchange
- YJ Nasdaq
- CNSP Nasdaq
- Market Cap
- YJ 8.1M
- CNSP 6.5M
- IPO Year
- YJ 2019
- CNSP 2019
- Fundamental
- Price
- YJ $1.74
- CNSP $0.10
- Analyst Decision
- YJ
- CNSP Strong Buy
- Analyst Count
- YJ 0
- CNSP 1
- Target Price
- YJ N/A
- CNSP $0.50
- AVG Volume (30 Days)
- YJ 220.1K
- CNSP 30.4M
- Earning Date
- YJ 11-21-2024
- CNSP 11-15-2024
- Dividend Yield
- YJ N/A
- CNSP N/A
- EPS Growth
- YJ N/A
- CNSP N/A
- EPS
- YJ N/A
- CNSP N/A
- Revenue
- YJ $66,957,730.00
- CNSP N/A
- Revenue This Year
- YJ N/A
- CNSP N/A
- Revenue Next Year
- YJ N/A
- CNSP N/A
- P/E Ratio
- YJ N/A
- CNSP N/A
- Revenue Growth
- YJ N/A
- CNSP N/A
- 52 Week Low
- YJ $1.42
- CNSP $0.10
- 52 Week High
- YJ $4.72
- CNSP $29.00
- Technical
- Relative Strength Index (RSI)
- YJ 51.64
- CNSP 41.55
- Support Level
- YJ $1.56
- CNSP $0.10
- Resistance Level
- YJ $1.79
- CNSP $0.11
- Average True Range (ATR)
- YJ 0.13
- CNSP 0.01
- MACD
- YJ 0.00
- CNSP -0.00
- Stochastic Oscillator
- YJ 64.29
- CNSP 7.69
About YJ Yunji Inc. American Depository Shares
Yunji Inc is a social e-commerce platform in China that offers a membership-based model that leverages the power of social interaction. The company provides a host of selected commodities such as beauty and personal care, mobile phones and digital products, baby and maternal products, toys, fruits, and other fresh products. It has expanded to operate its business, including the marketplace, on a diverse range of sales channels and other platforms. Geographically, the firm operates in China.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.